Zirconium Cyclosilicate Ion: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Zirconium Cyclosilicate Ion. Educational only — not medical advice.
Labeled uses
LOKELMA is indicated for the treatment of hyperkalemia in adults. Limitation of Use LOKELMA should not be used as an emergency treatment for life-threatening hyperkalemia because of its delayed onset of action [see Clinical Pharmacology (12.2) and Clinical Studies (14) ] .
Source: FDA labeling via NIH DailyMed (set 7f7ed64d…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.